GoodRx Holdings, Inc. - Common Stock (GDRX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
GDRX on Nasdaq
CUSIP
38246G108
Type / Class
Equity / Common Stock
Shares outstanding
98.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
117M
Holdings value
$496M
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
154
Number of buys
70
Number of sells
-107
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GoodRx Holdings, Inc. - Common Stock (GDRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FRANCISCO PARTNERS IV, L.P. 36% $288M 60.1M Francisco Partners GP IV, L.P. Mar 16, 2025
Idea Men, LLC 29.1% -10% $207M -$33.6M 43.2M -14% Idea Men, LLC Mar 21, 2025
VANGUARD GROUP INC 9.33% $38.9M 9.21M The Vanguard Group Sep 30, 2025
Bezdek Trevor 5.2% $25.9M 5.39M Trevor Bezdek Dec 16, 2024
Hirsch Douglas Joseph 5.2% $25.9M 5.39M Douglas Joseph Hirsch Dec 16, 2024
AMERIPRISE FINANCIAL INC 4.3% $22.2M 4.63M Ameriprise Financial, Inc. Mar 31, 2025
MILLENNIUM MANAGEMENT LLC 2.1% $10.5M 2.19M Millennium Management LLC Dec 31, 2024

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 117M $496M -$16.5M $4.23 154
2025 Q2 120M $600M -$4.66M $4.98 176
2025 Q1 122M $536M -$65.7M $4.41 164
2024 Q4 136M $632M -$55.1M $4.65 163
2024 Q3 142M $986M +$68.4M $6.94 165
2024 Q2 132M $1.03B +$24.3M $7.80 163
2024 Q1 129M $914M -$90.8M $7.10 156
2023 Q4 142M $949M +$31.1M $6.70 138
2023 Q3 138M $775M +$22.5M $5.63 152
2023 Q2 134M $738M -$18.2M $5.52 143
2023 Q1 136M $853M +$5.54M $6.25 151
2022 Q4 136M $633M -$16.4M $4.66 157
2022 Q3 140M $652M -$76.6M $4.67 160
2022 Q2 155M $916M -$35M $5.92 154
2022 Q1 146M $2.82B -$467M $19.33 158
2021 Q4 153M $4.99B +$337M $32.68 204
2021 Q3 140M $5.73B -$84.1M $41.02 212
2021 Q2 57.2M $2.06B +$356M $36.01 191
2021 Q1 132M $5.14B +$169M $39.02 195
2020 Q4 127M $5.13B +$41.6M $40.34 183
2020 Q3 36.8M $2.05B +$2.05B $55.60 143
2020 Q2 2.37K $85K $0 $35.91 1
2020 Q1 2.37K $85K $0 $35.91 1
2019 Q4 2.37K $85K $0 $35.91 1
2019 Q3 2.37K $85K $0 $35.91 1
2019 Q2 2.37K $85K $0 $35.91 1
2019 Q1 2.37K $85K $0 $35.91 1